Gytree.com announced its first round of fundraising, led by Biocon’s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma...
Continue ReadingLupin, a transnational pharmaceutical company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) to market its generic...
Continue ReadingDr. Reddy’s Laboratories Ltd. announced that it has acquired the trademark rights of the breast cancer drug Primcyv from Pfizer ProductsIndia Pvt Ltd for use...
Continue ReadingThe world’s first intranasal vaccine, christened as iNcovacc, is based on a delivery vehicle, a virus, that causes the common cold (adenovirus vector). The spike...
Continue ReadingPharmaceutical major Cipla NSE 0.46 % announced that its wholly-owned UK subsidiary Cipla (EU) Limited has signed definitive agreements to invest 15 million euros in...
Continue ReadingApproving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...
Continue ReadingCipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered company started its investment journey...
Continue ReadingDrugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization (CDSCO), in its minutes for the meeting held...
Continue ReadingHetero, a city-based leading pharmaceutical company announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of...
Continue Reading